Filing Details
- Accession Number:
- 0000950170-25-081200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-03 18:30:07
- Reporting Period:
- 2025-06-03
- Filing Date:
- 2025-06-03
- Accepted Time:
- 2025-06-03 18:30:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1815442 | Kymera Therapeutics Inc. | KYMR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1772518 | Elena Ridloff | C/O Kymera Therapeutics, Inc. 500 North Beacon Street, 4Th Floor Watertown MA 02472 | No | No | No | No |
Transaction Summary
| Sold: | 12,000 shares | Avg. Price: $46.10 | Total Value: $553,200.00 |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-03 | 12,000 | $27.67 | 12,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-03 | 7,200 | $45.50 | 4,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-03 | 4,800 | $47.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-03 | 12,000 | $0.00 | 12,000 | $27.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2033-06-15 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 25, 2024 adopted by the reporting person.
- The shares underlying this stock option are fully vested and exercisable.
Billionaire Hedge Funds
